Eli Lilly on Tuesday announced a $5 billion investment in a manufacturing facility in Virginia as the pharmaceutical giant looks to expand its domestic production capacity amid the threat of tariffs.

WASHINGTON — Pharmaceutical giant AbbVie paid health care providers roughly $145.7 million last year to promote its drugs, according to a STAT analysis of newly released government data. The massive ...

Following the reveal of President Donald Trump’s closely watched plan for branded pharmaceutical tariffs last week, several unknowns remained. Now, it appears the government is pushing pause on the ...

SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme Court ...

TrumpRx.gov is a proposed website that could allow consumers to purchase brand-name prescription drugs directly from the ...

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Maria Alonso ...

Austin, Texas, United States, December 2nd, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage ...

Austin, Texas, United States, December 3rd, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said ...

Hill Dermaceuticals, a Sanford-based pharmaceutical company, is beginning the application process to build a new ...

Topline results expected in the third quarter of 2025. SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company ...